Thoracoscopic anatomic segmentectomy for clinical stageⅠ lung cancer

乔玉磊; 林宗武; 奚俊杰

doi:10.3969/j.issn.1007-3969.2015.08.010

您当前的位置：

首页 >

文章列表页 >

Thoracoscopic anatomic segmentectomy for clinical stageⅠ lung cancer

更新时间：2025-12-31

- Thoracoscopic anatomic segmentectomy for clinical stageⅠ lung cancer
- China Oncology Vol. 25, Issue 8, Pages: 619-623(2015)
- 作者机构：
  
  复旦大学附属中山医院胸外科,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2015.08.010
  CLC：
- Published Online：14 December 2015，
  
  Published：14 December 2015
- 稿件说明：
移动端阅览
乔玉磊,林宗武,奚俊杰,等. 胸腔镜解剖性肺段切除术治疗临床Ⅰ期肺癌[J]. 中国癌症杂志, 2015, 25(8): 619-623.

乔玉磊, 林宗武, 奚俊杰. Thoracoscopic anatomic segmentectomy for clinical stageⅠ lung cancer[J]. China Oncology, 2015, 25(8): 619-623.
乔玉磊,林宗武,奚俊杰,等. 胸腔镜解剖性肺段切除术治疗临床Ⅰ期肺癌[J]. 中国癌症杂志, 2015, 25(8): 619-623. DOI： 10.3969/j.issn.1007-3969.2015.08.010.

乔玉磊, 林宗武, 奚俊杰. Thoracoscopic anatomic segmentectomy for clinical stageⅠ lung cancer[J]. China Oncology, 2015, 25(8): 619-623. DOI： 10.3969/j.issn.1007-3969.2015.08.010.

摘要

背景与目的：随着胸腔镜手术技术的提高，胸腔镜下解剖性肺段切除术日渐成熟。本文旨在研究胸腔镜肺段切除术用于治疗Ⅰ期肺癌患者的安全性、可行性及临床特点。方法：回顾性分析2008年3月—2014年1月复旦大学附属中山医院胸外科收治的临床诊断为Ⅰ期原发性支气管肺癌后接受胸腔镜解剖性肺段切除术的64例患者的临床资料，其中男性28例，女性36例，中位年龄59岁(39~86岁)。分析围术期各项参数。结果：64例患者顺利接受了胸腔镜解剖性肺段切除术。中位手术时间为120 min(90~240 min)，中位出血量为50 mL(10~200 mL)。术后中位胸管引流时间为3 d(2~7 d)，术后中位住院时间为5 d(3~23 d)。无围术期手术死亡病例，术后无严重并发症发生，无1例中转开胸，1例转为肺叶切除。51例毛玻璃样(ground glass opacity，GGO)病变患者的术后病理显示，浸润性腺癌30例，原位腺癌10例，微浸润腺癌6例，良性病变5例。结论：胸腔镜解剖性肺段切除对有经验的医师而言，是安全可行的，对临床Ⅰ期肺癌患者同时兼具了诊断和治疗的价值，尤其适用于GGO病变的患者。

Abstract

Background and purpose: With the improvement of skill of video-assisted thoracic surgery

thoracoscopic anatomic segmentectomy becomes more and more mature. This paper aimed to study the safety

feasibility and clinical features of thoracoscopic anatomic segmentectomy for stage Ⅰ lung cancer. Methods: Data from 64 patients who was diagnosed as having clinical Ⅰ stage lung cancer and received thoracoscopic anatomic pulmonary segmentectomy were retrospectively analyzed from Mar. 2008 to Jan. 2014. There were 28 men and 36 women with a median age of 59 years (39-86 years). Results: Sixty-four patients underwent thoracoscopic anatomic segmentectomy successfully. The median operative time was 120 min (90-240 min). The median blood loss in operation was 50 mL (10-200 mL). The median thoracic drainage time was 3 d(2-7 d). The median postoperative length of stay was 5 d(3-23 d). There was no postoperative mortality or severe complications. There was one conversion to lobectomy but no conversion to thoracotomy. There were 51 patients with ground glass opacity (GGO). Of the 51 patients

postoperative pathology showed invasive adenocarcinoma in 30

adenocarcinoma in situ in 10

minimally invasive adenocarcinoma in 6 and benign lesions in 5. Conclusion: Thoracoscopic anatomic pulmonary segmentectomy is a feasible and safe technique for a skilled doctor. Not only can it be a method of diagnosis

but also it can be a method of treatment for clinical stage Ⅰ lung cancer

especially for GGO in lung.

关键词

Keywords

references

Views

1828

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Important progress in surgical treatment of lung cancer in 2023

Research progress on H-E stained whole slide image analysis by artificial intelligence in lung cancer

Research progress on thyroid dysfunction induced by immunotherapy for lung cancer

Advances in fatty acid metabolism reprogramming of lung cancer

Detection of p53, PGP9.5, SOX2, GAGE7, GBU4-5 and MAGE A1 protein levels in lung cancer tissues and peripheral blood and their clinical value

Related Author

Bin QIAN

Haiquan CHEN

Mengqi JIANG

Yuchen HAN

Xiaolong FU

Haoting ZHANG

Jing ZHENG

Mengjiao FU

Related Institution

Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Thoracic Surgery, Jiangdu People’s Hospital of Yangzhou City

Institute of Thoracic Oncology, Fudan University

Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine

Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine

AI问答

⁰